Aicuris to Present Pritelivir and AIC468 Data at ID Week 2025
Aicuris will present an overview of the pritelivir clinical development program, including a comprehensive Phase 2 data overview, in two oral presentations. Updated safety and pharmacokinetic data from the Phase 1 trial of AIC468, an antiviral therapy for BKV infections,
More